Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life

This educational activity reviews currently approved prophylaxis therapy in hemophilia A, the benefits of prophylaxis and adherence, and patient quality-of-life factors. Interprofessional perspectives from an expert faculty panel are featured.

Axis Logo

Faculty

Miguel A. Escobar, MD
Medicine and Pediatrics at the University of Texas Health Science Center
Gulf States Hemophilia & Thrombophilia Center
Houston, Texas

Cindy Leissinger, MD
Tulane University School of Medicine
the Louisiana Center for Bleeding and Clotting Disorders
New Orleans, Louisiana

Guy Young, MD
the Hemostasis & Thrombosis Center
Children’s Hospital Los Angeles
the University of Southern California, Keck School of Medicine
Los Angeles, California

This activity is supported by an educational grant from Genentech, a member of the Roche Group


Continuing Education

Continuing Education Information: Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life



Read More
Review Article

Hemophilia A: Strategies for Improving Long-Term Holistic Management, Adherence, and Quality of Life

Miguel A. Escobar,(1) MD, Cindy Leissinger,(2) MD, and Guy Young,(3) MD

Read More
Copyright © 2010-2022 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.